Keywords
Bladder cancer
Clinical efficacy
prognosis
Submitted : 2023-11-26
Accepted : 2023-12-11
Published : 2023-12-26
Abstract
Objective: To explore the clinical benefits of transurethral resection of bladder tumors (TURBT) in treating bladder cancer. Methods: 60 bladder cancer cases were divided into a control group and an observational group according to their surgical plans. The control group underwent traditional open surgery, while the observation group underwent TURBT. The general surgical observation indicators, postoperative complication rates, and prognosis were compared between the two groups. Results: The operative time, urinary catheter indwelling time, and hospitalization time of the observation group were shorter than those of the control group. Besides, the observation group also had smaller intraoperative blood loss compared to the control group. The postoperative complications and the disease recurrence rate after 1 year of follow-up of the observation group were both lower than those of the control group (P < 0.05). There was no statistically significant difference in mortality between the two groups after 1 year of follow-up (P > 0.05). Conclusion: TURBT can shorten the operative time and accelerate the recovery of bladder cancer patients. Besides, it also has a lower risk of postoperative complications and recurrence. Therefore, it should be popularized in clinical practice.
References
Tang D, Zhou S, Zhang G, et al., 2023, Analysis of Risk Factors for Postoperative Recurrence of Non-Muscle Invasive Bladder Cancer After Primary Transurethral Resection of Bladder Tumors. Chinese Journal of Cancer, 33(5): 478–483.
Chen Y, Li H, Huang L, et al., 2023, Effects of Neoadjuvant Chemotherapy Combined with Transurethral Resection of Bladder Tumors on Tumor Diameter, Urinary Bladder Tumor Antigen Level, and Recurrence Rate in Patients with Bladder Cancer. Journal of Clinical Surgery, 31(2): 152–155.
Zhang Q, Li Y, Hu R, et al., 2023, Comparison of the Efficacy of Transurethral Holmium Laser Enucleation and Transurethral Resection of Bladder Tumors in Non-Muscle Invasive Bladder Cancer. Journal of Practical Clinical Medicine, 27(6): 133–136.
Di H, 2021, Comparison of Clinical Effects and Trauma Between Transurethral Holmium Laser Bladder Tumor Resection and Transurethral Resection of Bladder Tumors in the Treatment of Superficial Bladder Cancer. Chinese Modern Drug Application, 15(2): 70–72.
Zheng H, Yang W, Wang S, et al., 2020, Comparison of the Effects of Transurethral Holmium Laser Bladder Tumor Resection and Transurethral Resection of Bladder Tumors in The Treatment of Superficial Bladder Cancer. Journal of Practical Cancer, 35(4): 628–631.
Lin Y, 2021, Comparison of the Effects of Transurethral Bladder Tumor Enucleation and Bladder Tumor Resection in the Treatment of Non-Muscle Invasive Bladder Cancer. Fujian Medical Journal, 43(1): 102–105.
Xu W, Liu X, Ding K, 2021, Effects of Transurethral Resection of Bladder Tumors and Partial Cystectomy on Serum Tumor Markers and Prognosis in Patients with Bladder Cancer. Medical Theory and Practice, 34(17): 2998–3000.
Hu Z, Xu G, Wu X, 2023, Clinical Efficacy of Transurethral Resection of Bladder Tumors in Treating Bladder Cancer and its Impact on Patient Prognosis. Cancer Progress, 21(4): 451–453 + 464.
Liu H, Li S, Zhang L, 2022, Application Effect of Transurethral Resection of Bladder Tumors in Early Non-Muscle Invasive Bladder Cancer and its Impact on Patient Prognosis. Cancer Progress, 20(8): 836–839 + 847.
Zhang Q, Zhao A, Tan M, 2021, Effect of Transurethral Resection of Bladder Tumors on Serum TNF-?, APN, and VEGF Levels in Patients with Bladder Cancer. Clinical Medical Research and Practice, 6(3): 84–86.
Liu M, 2021, Effect of Transurethral Resection of Bladder Tumors in Treating Superficial Bladder Cancer. Chinese Journal of Civil Health, 33(2): 15–17.
Qin Y, Bai B, Zhang Z, 2020, Effect of Transurethral Resection of Bladder Tumors on Body Stress and Prognosis in Patients with Bladder Cancer. Harbin Medicine, 40(2): 110–112.